Researchers and patients with rare diseases are excited about recent advancements, but such experiments have their own sets of risks and challenges
With CRISPR gene editing, unique treatments begin to take off for rare diseases
Researchers and patients with rare diseases are excited about recent advancements, but such experiments have their own sets of risks and challenges